2023-10-012024-09-302024-09-30false09799120COATES MILL MEDICAL LIMITED2025-03-31falseiso4217:GBPxbrli:pure097991202023-10-01097991202024-09-30097991202023-10-012024-09-30097991202022-10-01097991202023-09-30097991202022-10-012023-09-3009799120bus:SmallEntities2023-10-012024-09-3009799120bus:AuditExempt-NoAccountantsReport2023-10-012024-09-3009799120bus:FullAccounts2023-10-012024-09-3009799120bus:PrivateLimitedCompanyLtd2023-10-012024-09-3009799120core:WithinOneYear2024-09-3009799120core:AfterOneYear2024-09-3009799120core:WithinOneYear2023-09-3009799120core:AfterOneYear2023-09-3009799120core:ShareCapital2024-09-3009799120core:SharePremium2024-09-3009799120core:RevaluationReserve2024-09-3009799120core:OtherReservesSubtotal2024-09-3009799120core:RetainedEarningsAccumulatedLosses2024-09-3009799120core:ShareCapital2023-09-3009799120core:SharePremium2023-09-3009799120core:RevaluationReserve2023-09-3009799120core:OtherReservesSubtotal2023-09-3009799120core:RetainedEarningsAccumulatedLosses2023-09-3009799120core:LandBuildings2024-09-3009799120core:PlantMachinery2024-09-3009799120core:Vehicles2024-09-3009799120core:FurnitureFittings2024-09-3009799120core:OfficeEquipment2024-09-3009799120core:NetGoodwill2024-09-3009799120core:IntangibleAssetsOtherThanGoodwill2024-09-3009799120core:ListedExchangeTraded2024-09-3009799120core:UnlistedNon-exchangeTraded2024-09-3009799120core:LandBuildings2023-09-3009799120core:PlantMachinery2023-09-3009799120core:Vehicles2023-09-3009799120core:FurnitureFittings2023-09-3009799120core:OfficeEquipment2023-09-3009799120core:NetGoodwill2023-09-3009799120core:IntangibleAssetsOtherThanGoodwill2023-09-3009799120core:ListedExchangeTraded2023-09-3009799120core:UnlistedNon-exchangeTraded2023-09-3009799120core:LandBuildings2023-10-012024-09-3009799120core:PlantMachinery2023-10-012024-09-3009799120core:Vehicles2023-10-012024-09-3009799120core:FurnitureFittings2023-10-012024-09-3009799120core:OfficeEquipment2023-10-012024-09-3009799120core:NetGoodwill2023-10-012024-09-3009799120core:IntangibleAssetsOtherThanGoodwill2023-10-012024-09-3009799120core:ListedExchangeTraded2023-10-012024-09-3009799120core:UnlistedNon-exchangeTraded2023-10-012024-09-3009799120core:MoreThanFiveYears2023-10-012024-09-3009799120core:Non-currentFinancialInstruments2024-09-3009799120core:Non-currentFinancialInstruments2023-09-3009799120dpl:CostSales2023-10-012024-09-3009799120dpl:DistributionCosts2023-10-012024-09-3009799120core:LandBuildings2023-10-012024-09-3009799120core:PlantMachinery2023-10-012024-09-3009799120core:Vehicles2023-10-012024-09-3009799120core:FurnitureFittings2023-10-012024-09-3009799120core:OfficeEquipment2023-10-012024-09-3009799120dpl:AdministrativeExpenses2023-10-012024-09-3009799120core:NetGoodwill2023-10-012024-09-3009799120core:IntangibleAssetsOtherThanGoodwill2023-10-012024-09-3009799120dpl:GroupUndertakings2023-10-012024-09-3009799120dpl:ParticipatingInterests2023-10-012024-09-3009799120dpl:GroupUndertakingscore:ListedExchangeTraded2023-10-012024-09-3009799120core:ListedExchangeTraded2023-10-012024-09-3009799120dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-10-012024-09-3009799120core:UnlistedNon-exchangeTraded2023-10-012024-09-3009799120dpl:CostSales2022-10-012023-09-3009799120dpl:DistributionCosts2022-10-012023-09-3009799120core:LandBuildings2022-10-012023-09-3009799120core:PlantMachinery2022-10-012023-09-3009799120core:Vehicles2022-10-012023-09-3009799120core:FurnitureFittings2022-10-012023-09-3009799120core:OfficeEquipment2022-10-012023-09-3009799120dpl:AdministrativeExpenses2022-10-012023-09-3009799120core:NetGoodwill2022-10-012023-09-3009799120core:IntangibleAssetsOtherThanGoodwill2022-10-012023-09-3009799120dpl:GroupUndertakings2022-10-012023-09-3009799120dpl:ParticipatingInterests2022-10-012023-09-3009799120dpl:GroupUndertakingscore:ListedExchangeTraded2022-10-012023-09-3009799120core:ListedExchangeTraded2022-10-012023-09-3009799120dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-10-012023-09-3009799120core:UnlistedNon-exchangeTraded2022-10-012023-09-3009799120core:NetGoodwill2024-09-3009799120core:IntangibleAssetsOtherThanGoodwill2024-09-3009799120core:LandBuildings2024-09-3009799120core:PlantMachinery2024-09-3009799120core:Vehicles2024-09-3009799120core:FurnitureFittings2024-09-3009799120core:OfficeEquipment2024-09-3009799120core:AfterOneYear2024-09-3009799120core:WithinOneYear2024-09-3009799120core:ListedExchangeTraded2024-09-3009799120core:UnlistedNon-exchangeTraded2024-09-3009799120core:ShareCapital2024-09-3009799120core:SharePremium2024-09-3009799120core:RevaluationReserve2024-09-3009799120core:OtherReservesSubtotal2024-09-3009799120core:RetainedEarningsAccumulatedLosses2024-09-3009799120core:NetGoodwill2023-09-3009799120core:IntangibleAssetsOtherThanGoodwill2023-09-3009799120core:LandBuildings2023-09-3009799120core:PlantMachinery2023-09-3009799120core:Vehicles2023-09-3009799120core:FurnitureFittings2023-09-3009799120core:OfficeEquipment2023-09-3009799120core:AfterOneYear2023-09-3009799120core:WithinOneYear2023-09-3009799120core:ListedExchangeTraded2023-09-3009799120core:UnlistedNon-exchangeTraded2023-09-3009799120core:ShareCapital2023-09-3009799120core:SharePremium2023-09-3009799120core:RevaluationReserve2023-09-3009799120core:OtherReservesSubtotal2023-09-3009799120core:RetainedEarningsAccumulatedLosses2023-09-3009799120core:NetGoodwill2022-10-0109799120core:IntangibleAssetsOtherThanGoodwill2022-10-0109799120core:LandBuildings2022-10-0109799120core:PlantMachinery2022-10-0109799120core:Vehicles2022-10-0109799120core:FurnitureFittings2022-10-0109799120core:OfficeEquipment2022-10-0109799120core:AfterOneYear2022-10-0109799120core:WithinOneYear2022-10-0109799120core:ListedExchangeTraded2022-10-0109799120core:UnlistedNon-exchangeTraded2022-10-0109799120core:ShareCapital2022-10-0109799120core:SharePremium2022-10-0109799120core:RevaluationReserve2022-10-0109799120core:OtherReservesSubtotal2022-10-0109799120core:RetainedEarningsAccumulatedLosses2022-10-0109799120core:AfterOneYear2023-10-012024-09-3009799120core:WithinOneYear2023-10-012024-09-3009799120core:Non-currentFinancialInstrumentscore:CostValuation2023-10-012024-09-3009799120core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-10-012024-09-3009799120core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-10-012024-09-3009799120core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-10-012024-09-3009799120core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-10-012024-09-3009799120core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-10-012024-09-3009799120core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-10-012024-09-3009799120core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-10-012024-09-3009799120core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-10-012024-09-3009799120core:Non-currentFinancialInstrumentscore:CostValuation2024-09-3009799120core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-3009799120core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-3009799120core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-3009799120core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-3009799120core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-3009799120core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-3009799120core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-3009799120core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-3009799120core:Non-currentFinancialInstrumentscore:CostValuation2023-09-3009799120core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-3009799120core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-3009799120core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-3009799120core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-3009799120core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-3009799120core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-3009799120core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-3009799120core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-3009799120bus:Director12023-10-012024-09-30

COATES MILL MEDICAL LIMITED

Registered Number
09799120
(England and Wales)

Unaudited Financial Statements for the Year ended
30 September 2024

COATES MILL MEDICAL LIMITED
Company Information
for the year from 1 October 2023 to 30 September 2024

Director

LINSELL, Robert David

Company Secretary

LINSELL, Laura Ann

Registered Address

Coates Mill House Corndean Lane
Winchcombe
Cheltenham
GL54 5NL

Registered Number

09799120 (England and Wales)
COATES MILL MEDICAL LIMITED
Balance Sheet as at
30 September 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets317,4411,032
17,4411,032
Current assets
Debtors415,51313,559
Cash at bank and on hand58,23214,406
73,74527,965
Creditors amounts falling due within one year5(58,151)(28,881)
Net current assets (liabilities)15,594(916)
Total assets less current liabilities33,035116
Net assets33,035116
Capital and reserves
Called up share capital100100
Profit and loss account32,93516
Shareholders' funds33,035116
The financial statements were approved and authorised for issue by the Director on 31 March 2025, and are signed on its behalf by:
LINSELL, Robert David
Director
Registered Company No. 09799120
COATES MILL MEDICAL LIMITED
Notes to the Financial Statements
for the year ended 30 September 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Vehicles5
Office Equipment3
2.Average number of employees

20242023
Average number of employees during the year32
3.Tangible fixed assets

Vehicles

Office Equipment

Total

£££
Cost or valuation
At 01 October 23-2,2392,239
Additions19,490-19,490
At 30 September 2419,4902,23921,729
Depreciation and impairment
At 01 October 23-1,2071,207
Charge for year2,5984833,081
At 30 September 242,5981,6904,288
Net book value
At 30 September 2416,89254917,441
At 30 September 23-1,0321,032
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables2,6591,557
Other debtors13,910
Prepayments and accrued income12,8538,092
Total15,51313,559
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables3,9225,923
Taxation and social security51,95522,958
Other creditors2,214-
Accrued liabilities and deferred income60-
Total58,15128,881
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.